Atea Pharmaceuticals, Inc. (AVIR)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch AVIR
Latest sale
$116k
Nov 19 · No plan
Form 4 sales
14
On record
Form 144 notices
15
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

3
Routine
1
Plan not stated
5
No plan
5
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 144 noticeNotice
    Dec 10, 2024 2024

    Filed to sell 359,606 shares ($1M)

    Berger Franklin M, Lead Independent Director

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 saleUnusual
    Dec 10, 2024 same day

    Sold 359,606 shares at $2.85 ($1M)

    Berger Franklin M, Director

    No 10b5-1 planSold 44.3% of holdings ($2.3M position)451,897 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 noticeNotice
    Nov 18, 2026 +708 days

    Filed to sell 18,252 shares ($72k)

    Polsky Bruce, Director

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 4 saleNo plan
    Nov 18, 2026 same day

    Sold 41,226 shares at $4.08 ($168k)

    Polsky Bruce, Director

    No 10b5-1 planSold 20.6% of holdings ($815k position)158,580 shares leftFirst sale on recordFiling

  5. 5 Form 144 noticeNotice
    Nov 19, 2026 +1 day

    Filed to sell 8,750 shares ($35k)

    Polsky Bruce, Director

    No 10b5-1 planFirst sale on recordFiling

  6. 6 Form 144 noticeNotice
    Nov 19, 2026 same day

    Filed to sell 22,619 shares ($89k)

    Lucidi Bruno, Director

    No 10b5-1 planFirst sale on recordFiling

  7. 7 Form 4 saleNo plan
    Nov 19, 2026 same day

    Sold 8,750 shares at $4.03 ($35k)

    Polsky Bruce, Director

    No 10b5-1 planSold 5.5% of holdings ($640k position)149,830 shares leftFollows a Form 144Filing

  8. 8 Form 4 saleNo plan
    Nov 19, 2026 same day

    Sold 29,360 shares at $3.96 ($116k)

    Lucidi Bruno, Director

    No 10b5-1 planSold 13.5% of holdings ($862k position)187,990 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (29)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for AVIR
Source
Nov 19, 2026Nov 19, 2026Lucidi BrunoAVIRDirectorForm 4 sale29,360$116k13.5%No planSEC
Nov 19, 2026Nov 19, 2026Polsky BruceAVIRDirectorForm 4 sale8,750$35k5.5%No planSEC
Nov 19, 2026Nov 19, 2026Lucidi BrunoAVIRDirectorForm 144 notice22,619$89kNoticeSEC
Nov 19, 2026Nov 19, 2026Polsky BruceAVIRDirectorForm 144 notice8,750$35kNoticeSEC
Nov 18, 2026Nov 18, 2026Polsky BruceAVIRDirectorForm 4 sale41,226$168k20.6%No planSEC
Nov 18, 2026Nov 18, 2026Polsky BruceAVIRDirectorForm 144 notice18,252$72kNoticeSEC
Dec 10, 2024Dec 12, 2024Berger Franklin MAVIRDirectorForm 4 sale359,606$1M44.3%UnusualSEC
Dec 10, 2024Dec 10, 2024Berger Franklin MAVIRLead Independent DirectorForm 144 notice359,606$1MNoticeSEC
Sep 19, 2024Sep 19, 2024Sommadossi Jean-PierreAVIRPresident, CEO, and ChairmanForm 4 sale57,969$234k1.0%RoutineSEC
Sep 19, 2024Sep 19, 2024JPM Partners LLCAVIRAffiliateForm 144 notice1,841$7kNoticeSEC
Sep 18, 2024Sep 18, 2024JPM Partners LLCAVIRAffiliateForm 144 notice22,187$89kNoticeSEC
Sep 17, 2024Sep 17, 2024JPM Partners LLCAVIRAffiliateForm 144 notice33,941$137kNoticeSEC
Jun 20, 2024Jun 21, 2024Polsky BruceAVIRDirectorForm 4 sale17,544$61k21.1%No planSEC
Jun 20, 2024Jun 20, 2024Polsky BruceAVIRDirectorForm 144 notice17,544$69kNoticeSEC
Jun 5, 2024Jun 7, 2024Sommadossi Jean-PierreAVIRPresident, CEO, and ChairmanForm 4 sale1,006$4k0.0%RoutineSEC
Jun 5, 2024Jun 5, 2024JPM Partners LLCAVIRAffiliateForm 144 notice1,006$4kNoticeSEC
Feb 1, 2024Feb 2, 2024Corcoran AndreaAVIROfficerForm 4 sale15,843$61k2.3%No planSEC
Feb 1, 2024Feb 2, 2024Sommadossi Jean-PierreAVIRPresident, CEO, and ChairmanForm 4 sale56,910$219k32.8%RoutineSEC
Feb 1, 2024Feb 2, 2024Horga Maria ArantxaAVIRChief Medical OfficerForm 4 sale15,870$61k38.2%UnusualSEC
Feb 1, 2024Feb 2, 2024Foster WayneAVIREVP, Chief Accounting OfficerForm 4 sale12,477$48k37.4%UnusualSEC
Feb 1, 2024Feb 2, 2024Vavricka JohnAVIRChief Commercial OfficerForm 4 sale11,819$45k35.5%UnusualSEC
Feb 1, 2024Feb 2, 2024Hammond Janet MJAVIRChief Development OfficerForm 4 sale14,029$54k28.4%UnusualSEC
Feb 1, 2024Feb 1, 2024Foster WayneAVIREVP, Chief Accounting OfficerForm 144 notice14,311$58kNoticeSEC
Feb 1, 2024Feb 1, 2024Sommadossi Jean-PierreAVIRPresident, CEO, and ChairmanForm 144 notice65,476$266kNoticeSEC
Feb 1, 2024Feb 1, 2024Hammond Janet MJAVIRChief Development OfficerForm 144 notice16,110$66kNoticeSEC
Feb 1, 2024Feb 1, 2024Corcoran AndreaAVIRCFO, EVP, Legal and SecretaryForm 144 notice18,198$74kNoticeSEC
Feb 1, 2024Feb 1, 2024Vavricka JohnAVIRChief Commercial OfficerForm 144 notice13,552$55kNoticeSEC
Feb 1, 2024Feb 1, 2024Horga Maria ArantxaAVIRChief Medical OfficerForm 144 notice18,227$74kNoticeSEC
Nov 14, 2022Nov 15, 2022Berger Franklin MAVIRDirectorForm 4 sale41,666$215k5.1%Plan not statedSEC